ATXS
Price
$7.46
Change
+$0.07 (+0.95%)
Updated
Sep 18, 04:59 PM (EDT)
Capitalization
410.28M
55 days until earnings call
PHVS
Price
$24.52
Change
+$0.44 (+1.83%)
Updated
Sep 18, 04:59 PM (EDT)
Capitalization
1.58B
48 days until earnings call
Interact to see
Advertisement

ATXS vs PHVS

Header iconATXS vs PHVS Comparison
Open Charts ATXS vs PHVSBanner chart's image
Astria Therapeutics
Price$7.46
Change+$0.07 (+0.95%)
Volume$8.19K
Capitalization410.28M
Pharvaris
Price$24.52
Change+$0.44 (+1.83%)
Volume$882
Capitalization1.58B
ATXS vs PHVS Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. PHVS commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and PHVS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 19, 2025
Stock price -- (ATXS: $7.40 vs. PHVS: $24.08)
Brand notoriety: ATXS and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 179% vs. PHVS: 366%
Market capitalization -- ATXS: $410.28M vs. PHVS: $1.58B
ATXS [@Biotechnology] is valued at $410.28M. PHVS’s [@Biotechnology] market capitalization is $1.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, PHVS is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 6 TA indicator(s) are bullish while PHVS’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 6 bullish, 4 bearish.
  • PHVS’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а -1.20% price change this week, while PHVS (@Biotechnology) price change was +3.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.96%. For the same industry, the average monthly price growth was +12.81%, and the average quarterly price growth was +39.84%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

PHVS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.58B) has a higher market cap than ATXS($410M). PHVS YTD gains are higher at: 25.613 vs. ATXS (-17.226). ATXS has higher annual earnings (EBITDA): -131.42M vs. PHVS (-165.21M). ATXS has more cash in the bank: 259M vs. PHVS (200M). PHVS has less debt than ATXS: PHVS (634K) vs ATXS (4.77M). ATXS (0) and PHVS (0) have equivalent revenues.
ATXSPHVSATXS / PHVS
Capitalization410M1.58B26%
EBITDA-131.42M-165.21M80%
Gain YTD-17.22625.613-67%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M200M130%
Total Debt4.77M634K752%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSPHVS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 21 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTUCX59.69N/A
N/A
Fidelity Advisor Telecommunications C
WEECX11.48N/A
N/A
TETON Westwood Equity A
LCGRX25.29N/A
N/A
Loomis Sayles Small Cap Growth Retail
UBVSX86.40N/A
N/A
Undiscovered Managers Behavioral Val I
GWGZX19.70N/A
N/A
AMG GW&K Small Mid Cap Core Z

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+1.79%
CRNX - ATXS
54%
Loosely correlated
+0.29%
XENE - ATXS
52%
Loosely correlated
+2.86%
NRIX - ATXS
50%
Loosely correlated
+1.54%
DNLI - ATXS
50%
Loosely correlated
-1.51%
OCUL - ATXS
49%
Loosely correlated
-2.17%
More